DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
Issue SH2 ·
Volume 69 ·
September 2001
DOI: 10.1055/s-002-1114
EDITORIAL
53
56
Bleich, S.;
Bleich, K.;
Wiltfang, J.;
Maler, J. M.;
Kornhuber, J.:
Glutamatergic Neurotransmission in Schizophrenics
62
Rietschel, M.:
Genetic Aspects of Individual Psychotropic Drug Response
65
Pollmächer, Th.;
Schuld, A.;
Kraus, Th.;
Haack, M.;
Hinze-Selch, D.:
On the Clinical Relevance of Clozapine-Triggered Release of Cytokines and Soluble Cytokine-Receptors
75
Meise, U.;
Sulzenbacher, H.;
Hinterhuber, H.:
Attempts to Overcome the Stigma of Schizophrenia
81
Schüttler, R.:
How can we Determine the Outcome of Schizophrenic Diseases?
86
Huber, G.:
How far is Psychopathology still meaningful for the Treatment of Schizophrenia?
92
Angst, J.;
Scharfetter, C.:
The Schizophrenic Spectrum: An Epidemiological Viewpoint
95
Gross, G.:
Therapy of Subclinical (Subdiagnostic) Syndromes of Schizophrenia Spectrum
101
Berner, P.:
New Concepts of Schizophrenic Sub-Syndromes - Consequences for Treatment:
104
Klosterkötter, J.;
Schultze-Lutter, F.:
Is there a Primary Prevention of Schizophrenic Psychiasis?
113
Gaebel, W.:
Strategies of Long-Term Medication in Schizophrenia
120
Saß, H.;
Jünemann, K.:
Etiological and Therapeutic Aspects of Schizoid and Schizotypal Personality Disorder
127
Süllwold, L.;
Herrlich, J.:
Psychological therapy of patients with schizophrenia: Trend of the concept development
132
Klingberg, S.;
Buchkremer, G.:
Cognitive Behavioral Treatment of Schizophrenia - Ways Towards Differential Indication
138
Böker, W.:
Psychotherapy for Schizophrenia
LAUDATIO
141